molecules of the month

“compound 60b”

RSV D486N-mut. fusion protein inh.

oral antiviral clinical candidate

from lower barrier to atropisomerism of lead

Bioorg. Med. Chem., Oct. 31, 2020

Taisho Pharmaceutical, Saitama, JP

Structure of compound 60b
1 min read

“compound 60b” (Taisho D486N mutant RSV fusion protein inhibitor clinical candidate)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: